Cerenome (PSTV) Finished Goods (2011 - 2019)
Plus Therapeutics (PSTV) posted quarterly Finished Goods of $1.7 million for Q1 2019, down 13.33% year-over-year from $1.9 million in Q1 2018, and up 2.69% quarter-over-quarter from $1.6 million in Q4 2018.
Cerenome (PSTV) Finished Goods (2011 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has reported Finished Goods for 9 consecutive years, with $1.7 million the latest figure, recorded in Q1 2019.
- In Q1 2019, Finished Goods fell 13.33% year-over-year to $1.7 million; the TTM figure through Mar 2019 stood at $1.7 million (down 13.33% YoY), while the FY2018 annual figure was $1.6 million, down 8.2% from the prior year.
- Finished Goods rose to $1.7 million in Q1 2019 per PSTV's latest filing, from $1.6 million in the prior quarter.
- Across five years, Finished Goods topped out at $2.5 million in Q4 2015 and bottomed at $1.5 million in Q1 2015.
- Historically, Finished Goods has averaged $1.9 million across 5 years, with a median of $1.8 million in 2017.
- Annual changes were most pronounced in 2015 — Finished Goods slumped 33.92% — and 2016, when it jumped 50.79%.
- Plus Therapeutics' Finished Goods stood at $2.5 million in 2015, then retreated by 26.45% to $1.8 million in 2016, then dropped by 2.14% to $1.8 million in 2017, then decreased by 8.2% to $1.6 million in 2018, then grew by 2.69% to $1.7 million in 2019.
- Business Quant data shows PSTV's Finished Goods at $1.7 million in Q1 2019, $1.6 million in Q4 2018, and $1.7 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 1.68 Mn |
| Dec 31, 2018 | 1.63 Mn |
| Sep 30, 2018 | 1.70 Mn |
| Jun 30, 2018 | 1.84 Mn |
| Mar 31, 2018 | 1.94 Mn |
| Dec 31, 2017 | 1.78 Mn |
| Sep 30, 2017 | 1.76 Mn |
| Jun 30, 2017 | 1.73 Mn |
| Mar 31, 2017 | 1.75 Mn |
| Dec 31, 2016 | 1.82 Mn |
| Sep 30, 2016 | 2.18 Mn |
| Jun 30, 2016 | 2.36 Mn |
| Mar 31, 2016 | 2.29 Mn |
| Dec 31, 2015 | 2.47 Mn |
| Sep 30, 2015 | 1.72 Mn |
| Jun 30, 2015 | 1.69 Mn |
| Mar 31, 2015 | 1.52 Mn |
| Dec 31, 2014 | 1.81 Mn |
| Sep 30, 2014 | 2.60 Mn |
| Jun 30, 2014 | 2.25 Mn |